Peter Nowak spoke to the iBIONICS team for The Globe and Mail article on the Diamond Eye™ solution to blindness. The report includes interviews with CEO and Cofounder Suzanne Grant, CTO and Cofounder Professor Steven Prawer, and Chief Clinical Officer Dr Flavio Rezende. Read the full article here.
iBIONICS' Cofounder and CEO, Suzanne Grant, also a Canadian Veteran, Highlights the Importance of the Invictus Games
iBIONICS is demonstrated how its Diamond Eye™ will restore vision at the Accessibility Innovation Showcase at the Invictus Games. The Accessibility Innovation Showcase highlighted advanced technology that can improve accessibility for people with injuries and health challenges.
"The Invictus Games have extra meaning to me, because I'm a veteran," says iBIONICS Cofounder and CEO Suzanne Grant who served as a Communications and Electronics Engineering Officer for 13 years from 1982 to 1995. "I've had friends and family injured while on mission, so I feel strongly about the positive impact of the Invictus Games."
At the Invictus Games Accessibility Innovation Showcase, Suzanne Grant presented iBIONICS' Diamond Eye and demonstrated how this game-changing technology will help blind people see again. The iBIONICS technology uses implants to replicate natural functions inside of the body. iBIONICS' solution will operate with technologies like augmented reality, artificial intelligence, advanced neurostimulation algorithms, facial recognition software, and uses virtual reality for rehabilitation.
iBIONICS Attracts Leading Bionic Scientist, Professor Jim Patrick, to Post of Advisory Board Chair
The iBIONICS Diamond Eye team is delighted to announce that Professor Jim Patrick of cochlear implant fame has joined as Chair of the iBIONICS Advisory Board. Professor Patrick was part of the early development team of the cochlear implant, and has been a key member of the team that has seen Cochlear Limited grow to a company that has supplied implants to over 300,000 hearing impaired people worldwide.
Ontario Bioscience Innovation Organization Provides Opportunity for iBIONICS to Access Investment
iBIONICS and their groundbreaking Diamond Eye project continue to gather accolades and honours. Most recently, iBIONICS was selected as one of 10 high potential early stage bioscience startup companies to participate in the 2017 Capital Access Advisory Program (CAAP®) of Ontario Bioscience Innovation Organization (OBIO). Selection into this program, now in its 5th year, is further evidence that the iBIONICS’ effort to restore partial sight is one of the bright lights in Ontario’s bioscience startup community.
The Diamond Eye Gets Prestigious National Award
Ottawa, Canada, November 29, 2016 - After being given top provincial honours, iBIONICS has now won Startup Canada’s National Innovation Award for their work in developing a solution for blindness. Startup Canada Innovation Award is awarded to a Canadian company exhibiting excellence in innovation through leveraging new knowledge or technology in solving real world problems. The annual Startup Canada Awards are the hallmark event that celebrate and recognize those driving impact and demonstrating excellence in Canada’s entrepreneurship and innovation community.
Thursday, December 1, 2016, 4-5:30 pm
Harvard University, Department of Physics, Jefferson Laboratory 250
17 Oxford Street, Cambridge, Massachusetts
Professor Steven Prawer, Cofounder and CTO of iBIONICS, lead inventor of the Diamond Eye and Scientific Advisor to Stentrode (as explained by President Obama on the Science Channel) provides a glimpse into the future. A future where implants, bionics, and human-machine interfaces will become the new normal.
Melbourne, Australia, November 9, 2016 - Researchers from the Department of Physics at the University of Melbourne (Dr David Garrett and Professor Steven Prawer) and the National Vision Research Institute (NVRI) of Australia founded by the Australian College of Optometry (Professor Michael Ibbotson and Associate Professor Hamish Meffin) have won a $1 M dollar grant from the National Health and Medical Research Council (NHMRC). The grant will be used to help demonstrate that their next generation diamond retinal implant can dramatically improve the quality of vision experienced by bionic eye users.
Accolades Keep Coming for the Diamond Eye
Ottawa, Canada, October 4, 2016 - iBIONICS has won Startup Canada’s Innovation Award 2016 in the Quebec Region for their work towards finding a solution for blindness. Startup Canada’s Innovation Award is given to a Canadian company exhibiting excellence in innovation, in any sector, through leveraging new knowledge or technology to solve real world problems.
The Diamond Eye Project has Exciting New Collaboration with University of Ottawa
Ottawa, Canada, August 23, 2016 - iBIONICS has announced that they have chosen the SUNLAB, part of the Centre for Research in Photonics at the University of Ottawa, one of the foremost photonics centres in the world, for collaboration in developing the wireless capability to transfer data and power for their Diamond Eye solution to blindness. This will be accomplished with the development of a high efficiency photovoltaic (PV) cell.
Diamond Eye Startup Selected as Favourite for Technology Entrepreneurship Project
Ottawa, Canada, August 22, 2016 - iBIONICS competed with Ottawa’s top startups and has won at the School Your Startup Pitchfest. This marks the beginning of an important relationship between the emerging medical device company and a team of six Executive MBA consultants, who selected iBIONICS’ Diamond Eye for their technology entrepreneurship project.